Consumer products containing cannabis-derived CBN to be banned starting June

The decision to ban consumer products containing CBN reflects a growing trend among governments to regulate cannabis-derived substances more strictly. While the intention is to protect public health and ensure that vulnerable patients receive necessary treatments, it raises questions about access to alternative therapies for those who may benefit from CBN. The balance between regulation and patient access will be crucial moving forward.